
Guardian Pharmacy Service (GRDN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0.33 | $0.31 | 6.45 % |
| Q2 | Aug 6, 2026 | $0.29 | $0.26 | 11.5 % |
| Q1 | May 6, 2026 | $0.29 | $0.24 | 20.8 % |
| Q4 | Mar 11, 2026 | $0.37 | $0.26 | 42.3 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $371.07M | $365.39M | 1.55 % |
| Q2 | Aug 6, 2026 | $351.77M | $340.29M | 3.37 % |
| Q1 | May 6, 2026 | $336.60M | $329.85M | 2.05 % |
| Q4 | Mar 11, 2026 | $397.62M | $389.33M | 2.13 % |
Guardian Pharmacy Service (GRDN) publicó su última previsión de noviembre 5, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $1.44B - $1.46B para el período.
En comparación con la previsión anterior, Guardian Pharmacy Service mantenido redujo su previsión de ingresos desde un rango anterior de $1.43B - $1.45B.
Guardian Pharmacy Service ha emitido 14 actualizaciones de orientación entre el noviembre 12, 2024 y el noviembre 5, 2026. During this period, the company raised its outlook 5 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.31 | $0.26 | $0.24 | $0.26 |
| Actual | $0.33 | $0.29 | $0.29 | $0.37 |
| Surprise | +6.45% | +11.5% | +20.8% | +42.3% |
| Revenue | ||||
| Estimate | $365.4M | $340.3M | $329.8M | $389.3M |
| Actual | $371.1M | $351.8M | $336.6M | $397.6M |
| Surprise | +1.55% | +3.37% | +2.05% | +2.13% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.44 | $0.29 | $0.31 | $0.33 |
| Revenue | ||||
| Consensus | $393.0M | $361.3M | — | — |